Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma

Pancreatic cancer is a leading cause of cancer mortality and is projected to become the second-most common cause of cancer mortality in the next decade. While gene-wide association studies and next generation sequencing analyses have identified molecular patterns and transcriptome profiles with prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Giorgio, Cristina, Lupia, Antonio, Marchianò, Silvia, Bordoni, Martina, Bellini, Rachele, Massa, Carmen, Urbani, Ginevra, Roselli, Rosalinda, Moraca, Federica, Sepe, Valentina, Catalanotti, Bruno, Morretta, Elva, Monti, Maria Chiara, Biagioli, Michele, Distrutti, Eleonora, Zampella, Angela, Fiorucci, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657739/
https://www.ncbi.nlm.nih.gov/pubmed/36359879
http://dx.doi.org/10.3390/cells11213482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657739/
https://www.ncbi.nlm.nih.gov/pubmed/36359879
http://dx.doi.org/10.3390/cells11213482

Ejemplares similares